Full-Time
MicroVentures
51-200 employees
Equity crowdfunding platform for investors
No salary listed
Junior, Mid
Austin, TX, USA
Get referrals →
You have ways to get a MicroVentures referral from your network.
Applications through a referral are 3x more likely to get an interview!
Upload your resume to see how it matches 2 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
- You must have a strong understanding of financing and accounting
- You must be familiar with the investment due diligence process
- You must have excellent interpersonal skills and a demonstrated ability to thrive in an entrepreneurial environment with limited supervision
- Strong writing and grammar skills are a must
- A due diligence writing sample will be requested
- Reading/reviewing business plans and pitch decks
- Assessing market/company attractiveness to help identify compelling businesses
- Involvement in all aspects of due diligence on new investments (business analysis, industry theses, competitive landscape, business/pricing model, and data collection)
- Writing comprehensive research reports about investment opportunities
- Skillfully mining data sources for relevant information
- Startup Analysis
- Market/vertical research
- Startup competition research
- Analysis of each startup’s investor documents and capital raise details
- Staying current on tech industry trends
- Reviewing and understanding investor documents and other capital raise details
- Constructing accurately detailed summaries of the startup’s business model
- Finding accurate information from reputable sources
- Monitoring the venture capital and tech startup landscape
MicroVentures operates an equity crowdfunding platform that allows both accredited and non-accredited investors to invest in high-growth startups and private market opportunities. The platform simplifies the investment process by providing access to early-stage investments that were once limited to venture capitalists and institutional investors. MicroVentures generates revenue through a dual-fee structure, where investors pay a fee based on their investment amount, and companies pay a fee to list their fundraising campaigns. Additionally, the company offers educational resources to help investors understand the risks and make informed decisions about equity crowdfunding. This focus on accessibility and education sets MicroVentures apart from its competitors in the fintech market.
Company Size
51-200
Company Stage
N/A
Total Funding
$3.2M
Headquarters
Austin, Texas
Founded
2009
Simplify's Take
What believers are saying
- Growing interest in equity crowdfunding supports MicroVentures' business model.
- Increased demand for community-driven investment platforms aligns with MicroVentures' offerings.
- Biotechnology sector's growth presents opportunities for MicroVentures to support medical research.
What critics are saying
- Rising competition from new crowdfunding platforms like Anfin.
- Potential market saturation in the equity crowdfunding space.
- Regulatory scrutiny in the fintech sector could impact MicroVentures.
What makes MicroVentures unique
- MicroVentures connects both accredited and non-accredited investors with startups.
- The platform offers early-stage investment opportunities traditionally limited to venture capitalists.
- MicroVentures uses a dual-fee structure, earning from both investors and companies.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
401(k) Retirement Plan
401(k) Company Match
Company Equity
Performance Bonus
Company News
Oakland-based Mighty Buildings, which is on a quest to build homes using 3D printing, robotics and automation, has raised a $22 million extension to its Series B round of funding. The company claims to be able to 3D print structures “two times as quickly with 95% less labor hours and 10-times less waste” than conventional construction. For example, it says it can 3D print a 350-square-foot studio apartment in just 24 hours.
3D Printed Biodegradable Mesh Designed to Deliver Cancer Drugs Directly to Tumor Site With Greater Efficacy, Reduced Side Effects
ICON, in one of the largest seed rounds for Texas start-ups in 2018, announces $9M in funding.
Rochester, MN | February 10, 2023 – Pneumeric Inc., developers of the Capnospot™ - A disposable medical device that allows visual detection of carbon dioxide during treatment of a collapsed lung with needle decompression, has raised nearly $40,000 from 124 investors through its recently launched equity crowdfunding campaign. These funds build on the $1.2 million Pneumeric has
BOSTON, Aug. 15, 2022 /PRNewswire/ -- Remedium Bio, Inc., a biotechnology company developing novel gene therapies, today announced that it has closed more than $2.3M in its expanded seed round financing. Funding from the raise is being used to study Remedium's lead product, a single-injection gene therapy potentially capable of reversing cartilage loss, in a collaboration with Tufts University School of Medicine scientists researching rheumatic disorders. The financing was led by Sherwood Ventures and included participation from, LongevityTech.Fund, Primo Medical Group, Angel Star Ventures, Apis Health Angels, MicroVentures, and Guindy Alumni Angels. Potential to reverse years of age-related cartilage loss Tweet this We believe that any disease can be cured. - Remedium Bio